Researchers at the University of Miami have developed a “tumor-on-a-chip” microfluidic device that enables real-time observation of pancreatic cancer, according to a study published in the journal Biofabrication. By recreating the complex tumor microenvironment in three dimensions, the team identified how immune cells are co-opted to shield tumors from treatment, offering potential new targets for therapeutic intervention.
How the “Tumor-on-a-Chip” Works
Traditional laboratory models, such as flat, two-dimensional cell cultures, often fail to capture the structural complexity of pancreatic cancer. To solve this, researchers at the Sylvester Comprehensive Cancer Center and the University of Miami College of Engineering created a handheld microfluidic platform. This device allows scientists to observe 3D tumor architecture while enabling immune cells to flow through the system, mimicking actual human biological conditions.
Ashutosh Agarwal, Ph.D., senior author of the study and a professor of biomedical engineering at the University of Miami, describes the shift as moving from a “still image to a live broadcast.” This technology allows researchers to visualize previously invisible interactions that contribute to treatment resistance.
Why Pancreatic Cancer Resists Current Therapies
The research, led by Dr. Jashodeep Datta, a pancreatic and hepatobiliary surgical oncologist at Sylvester, reveals that pancreatic cancer acts as an evolving ecosystem. A critical finding involves myeloid-derived suppressor cells. Instead of attacking the tumor, these immune cells reshape the environment to support cancer growth.
According to the study, these immune cells push fibroblasts—cells responsible for shaping tissue structure—into an inflammatory state. Once activated, these fibroblasts release signals that suppress the immune response and create a reinforcing cycle of tumor protection. Dr. Datta notes that “if you want to treat the disease effectively, you have to understand how all of these components interact and reinforce each other.”
What Are the Next Steps for Cancer Treatment?
Current treatment strategies often focus on the direct elimination of cancer cells. However, this study suggests that interrupting the communication between the tumor and the immune system could be more effective. By targeting the signals that drive inflammation, researchers believe they may be able to weaken the tumor’s protective barrier.
The study also identified a population of precursor fibroblast cells that appear primed to become inflammatory. Researchers suggest these cells act as a “reserve force.” Because these cells are already on a path toward becoming pro-inflammatory, they represent a specific, previously underrecognized point of intervention for future drug development.
Frequently Asked Questions
What is a tumor-on-a-chip?
It is a micro-engineered device, roughly the size of a handheld tool, that recreates the 3D environment of a tumor. It allows scientists to observe how cancer cells, immune cells, and structural cells interact in real time.
Why is pancreatic cancer difficult to treat?
Pancreatic tumors are surrounded by a dense, structural “microenvironment” that acts as a shield, blocking therapies and suppressing the body’s natural immune response, according to the research team at Sylvester Comprehensive Cancer Center.
Can this technology be used for other diseases?
Yes. While this study focused on pancreatic cancer, researchers noted that the platform’s ability to replicate dynamic biological environments makes it suitable for studying other cancers and various chronic inflammatory diseases.
Are you interested in how medical technology is changing the landscape of oncology? Share your thoughts in the comments below or subscribe to our research newsletter for monthly updates on the latest clinical breakthroughs.
